Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study.
Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study.
复制标题
DOI：
10.1186/s12883-021-02220-w
复制
发表时间：
2021-07-15
期刊：
影响因子：
2.6
通讯作者：
García-Azorín D
中科院分区：
文献类型：
--
作者：
Trigo-López J;Guerrero-Peral ÁL;Sierra Á;Martínez-Pías E;Gutiérrez-Sánchez M;Huzzey E;García-Azorín D
我们的目的是描述和比较患者和全科医生对偏头痛急性和预防性治疗相关的不同变量的意见。进行了一项观察性描述性研究。来自我们医疗保健领域的发作性偏头痛患者和全科医生被邀请回答关于偏头痛治疗相关的不同变量的调查。他们被要求对不同的变量发表意见，并考虑以百分比表示的预期疗效和预期的治疗作用时间。选择了55名患者和55名全科医生。有效性被认为是对症和预防治疗的最重要变量。成本被认为是最不重要的变量。患者对对症治疗和预防治疗的预期疗效百分比分别为84.0%（±16.7%）和79.9%（±17.1%）。全科医生对对症治疗和预防治疗的预期疗效百分比分别为75.0%（± 14.0%）和70.4%（± 14.3%）。对于对症治疗，选择患者的疼痛停止预期作用时间为27.5 min（±13.8），GP为24.0 min（±18.3）。对于预防性治疗，患者的预期作用时间为7.1天（±4.5），全科医生的预期作用时间为13.9天（±8.9）。最重要的终点是，对于急性：有效性，短的作用时间和持久的影响。预防性：有效性、持续作用和耐受性。患者和全科医生都同意最喜欢和最不喜欢的终点。对症治疗和预防治疗的预期有效率均在75%以上;急性治疗的预期作用时间低于30 min，预防治疗的预期作用时间低于2周。
We aim to describe and compare patients and general practitioners’ opinions about the different variables related to acute and preventive treatment for migraine. An observational descriptive study was performed. Patients with episodic migraine and general practitioners, from our healthcare area, were invited to answer a survey about the different variables related to migraine treatment. They were asked for their opinions on the different variables, and to consider the desired efficacy in percentage terms and the desired action times of treatment. Fifty-five patients and fifty-five general practitioners were selected. Effectiveness was considered the most important variable for symptomatic and preventive treatment. Cost was considered the least important variable. Patients desired percentage of efficacy was 84.0% (±16.7%) for symptomatic treatment and 79.9% (±17.1%) for preventive treatment. General practitioners desired percentage of efficacy was 75.0% (±14.0) for symptomatic treatment and 70.4% (±14.3) for preventive treatment. For symptomatic treatment the desired action time for pain cessation was selected as 27.5 min (±13.8) for patients and 24.0 min (±18.3) for GPs. For preventive treatment the desired action time for effect was 7.1 days (±4.5) for patients and 13.9 days (±8.9) for general practitioners. The most important endpoints were, for acute: effectiveness, a short action time and a persistent effect. For prophylactic: effectiveness, sustained effect and tolerability. Both patients and general practitioners agreed on the most and least preferred endpoints. Desired percentage of efficacy was above 75% for both symptomatic and preventive treatment; and the desired action time was below 30 min for acute treatment and 2 weeks for preventive treatment.
登录
查看更多内容
DOI：
10.1177/0333102417731348
发表时间：
2018-06
期刊：
Cephalalgia : an international journal of headache
影响因子：
--
作者：
Haywood KL;Mars TS;Potter R;Patel S;Matharu M;Underwood M
通讯作者：
Underwood M
影响因子：
39.2
作者：
MacGregor, E Anne
通讯作者：
MacGregor, E Anne
影响因子：
5
作者：
Tepper, Stewart J.;Chen, Susy;Rapoport, Alan M.
通讯作者：
Rapoport, Alan M.
影响因子：
4.9
作者：
Diener, Hans-Christoph;Tassorelli, Cristina;Mandrekar, Jay
通讯作者：
Mandrekar, Jay
影响因子：
7.4
作者：
Raffaelli, Bianca;Mussetto, Valeria;Reuter, Uwe
通讯作者：
Reuter, Uwe